A Study Of New Medicine (GSK 372475) For The Treatment Of Depression

NCT00448058 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

396

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder

Interventions

DRUG: GSK372475
DRUG: venlafaxine
DRUG: placebo

Sponsor

GlaxoSmithKline